8-7470474-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001040702.1(DEFB104B):c.101C>T(p.Thr34Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00080 ( 0 hom., cov: 2)
Exomes 𝑓: 0.0014 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
DEFB104B
NM_001040702.1 missense
NM_001040702.1 missense
Scores
3
2
10
Clinical Significance
Conservation
PhyloP100: 2.64
Genes affected
DEFB104B (HGNC:26165): (defensin beta 104B) Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions. Chromosome 8p23 contains at least two copies of the duplicated beta-defensin cluster. This duplication results in two identical copies of defensin, beta 104, DEFB104A and DEFB104B, in head-to-head orientation. This gene, DEFB104B, represents the more telomeric copy. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.11798793).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB104B | NM_001040702.1 | c.101C>T | p.Thr34Ile | missense_variant | 2/2 | ENST00000316169.2 | NP_001035792.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB104B | ENST00000316169.2 | c.101C>T | p.Thr34Ile | missense_variant | 2/2 | 1 | NM_001040702.1 | ENSP00000322191.2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 4968Hom.: 0 Cov.: 2 FAILED QC
GnomAD3 genomes
AF:
AC:
5
AN:
4968
Hom.:
Cov.:
2
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00108 AC: 23AN: 21222Hom.: 0 AF XY: 0.00123 AC XY: 14AN XY: 11376
GnomAD3 exomes
AF:
AC:
23
AN:
21222
Hom.:
AF XY:
AC XY:
14
AN XY:
11376
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00138 AC: 251AN: 181282Hom.: 0 Cov.: 0 AF XY: 0.00128 AC XY: 121AN XY: 94256
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
251
AN:
181282
Hom.:
Cov.:
0
AF XY:
AC XY:
121
AN XY:
94256
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000805 AC: 4AN: 4970Hom.: 0 Cov.: 2 AF XY: 0.00146 AC XY: 3AN XY: 2050
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4
AN:
4970
Hom.:
Cov.:
2
AF XY:
AC XY:
3
AN XY:
2050
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.101C>T (p.T34I) alteration is located in exon 2 (coding exon 2) of the DEFB104B gene. This alteration results from a C to T substitution at nucleotide position 101, causing the threonine (T) at amino acid position 34 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MutPred
Loss of phosphorylation at T34 (P = 0.0342);
MVP
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at